SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $441,523 | +141.3% | 12,378 | +128.6% | 0.06% | +6.8% |
| Q3 2022 | $183,000 | -99.9% | 5,414 | +4.3% | 0.06% | +18.0% |
| Q2 2022 | $150,095,000 | +102704.8% | 5,190 | +14.8% | 0.05% | +28.2% |
| Q1 2022 | $146,000 | +139.3% | 4,519 | +98.9% | 0.04% | +77.3% |
| Q3 2021 | $61,000 | +19.6% | 2,272 | +37.2% | 0.02% | +15.8% |
| Q2 2021 | $51,000 | +96.2% | 1,656 | +65.4% | 0.02% | +26.7% |
| Q1 2021 | $26,000 | – | 1,001 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |